163 related articles for article (PubMed ID: 11781307)
1. Contribution of estrogen receptor alpha to oncogenic K-Ras-mediated NIH3T3 cell transformation and its implication for escape from senescence by modulating the p53 pathway.
Kato K; Horiuchi S; Takahashi A; Ueoka Y; Arima T; Matsuda T; Kato H; Nishida Ji J; Nakabeppu Y; Wake N
J Biol Chem; 2002 Mar; 277(13):11217-24. PubMed ID: 11781307
[TBL] [Abstract][Full Text] [Related]
2. p53-independent activation of the hdm2-P2 promoter through multiple transcription factor response elements results in elevated hdm2 expression in estrogen receptor alpha-positive breast cancer cells.
Phelps M; Darley M; Primrose JN; Blaydes JP
Cancer Res; 2003 May; 63(10):2616-23. PubMed ID: 12750288
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic ras and p53 cooperate to induce cellular senescence.
Ferbeyre G; de Stanchina E; Lin AW; Querido E; McCurrach ME; Hannon GJ; Lowe SW
Mol Cell Biol; 2002 May; 22(10):3497-508. PubMed ID: 11971980
[TBL] [Abstract][Full Text] [Related]
4. MDM2 enhances the function of estrogen receptor alpha in human breast cancer cells.
Saji S; Okumura N; Eguchi H; Nakashima S; Suzuki A; Toi M; Nozawa Y; Saji S; Hayashi S
Biochem Biophys Res Commun; 2001 Feb; 281(1):259-65. PubMed ID: 11178989
[TBL] [Abstract][Full Text] [Related]
5. 58-kDa microspherule protein (MSP58) is novel Brahma-related gene 1 (BRG1)-associated protein that modulates p53/p21 senescence pathway.
Hsu CC; Lee YC; Yeh SH; Chen CH; Wu CC; Wang TY; Chen YN; Hung LY; Liu YW; Chen HK; Hsiao YT; Wang WS; Tsou JH; Tsou YH; Wu MH; Chang WC; Lin DY
J Biol Chem; 2012 Jun; 287(27):22533-48. PubMed ID: 22563078
[TBL] [Abstract][Full Text] [Related]
6. Tumorigenesis of K-ras mutation in human endometrial carcinoma via upregulation of estrogen receptor.
Tu Z; Gui L; Wang J; Li X; Sun P; Wei L
Gynecol Oncol; 2006 May; 101(2):274-9. PubMed ID: 16303170
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the K-ras and p53 pathways in X-ray-induced lung tumors in the rat.
Belinsky SA; Middleton SK; Picksley SM; Hahn FF; Nikula KJ
Radiat Res; 1996 Apr; 145(4):449-56. PubMed ID: 8600505
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic ras activates the ARF-p53 pathway to suppress epithelial cell transformation.
Lin AW; Lowe SW
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5025-30. PubMed ID: 11309506
[TBL] [Abstract][Full Text] [Related]
9. Ras inhibition leads to transcriptional activation of p53 and down-regulation of Mdm2: two mechanisms that cooperatively increase p53 function in colon cancer cells.
Halaschek-Wiener J; Wacheck V; Kloog Y; Jansen B
Cell Signal; 2004 Nov; 16(11):1319-27. PubMed ID: 15337531
[TBL] [Abstract][Full Text] [Related]
10. Caveolin-1 regulates the antagonistic pleiotropic properties of cellular senescence through a novel Mdm2/p53-mediated pathway.
Bartholomew JN; Volonte D; Galbiati F
Cancer Res; 2009 Apr; 69(7):2878-86. PubMed ID: 19318577
[TBL] [Abstract][Full Text] [Related]
11. MDMX stability is regulated by p53-induced caspase cleavage in NIH3T3 mouse fibroblasts.
Gentiletti F; Mancini F; D'Angelo M; Sacchi A; Pontecorvi A; Jochemsen AG; Moretti F
Oncogene; 2002 Jan; 21(6):867-77. PubMed ID: 11840332
[TBL] [Abstract][Full Text] [Related]
12. Regulation of cellular response to oncogenic and oxidative stress by Seladin-1.
Wu C; Miloslavskaya I; Demontis S; Maestro R; Galaktionov K
Nature; 2004 Dec; 432(7017):640-5. PubMed ID: 15577914
[TBL] [Abstract][Full Text] [Related]
13. A modified p53 overcomes mdm2-mediated oncogenic transformation: a potential cancer therapeutic agent.
Lin J; Jin X; Page C; Sondak VK; Jiang G; Reynolds RK
Cancer Res; 2000 Oct; 60(20):5895-901. PubMed ID: 11059788
[TBL] [Abstract][Full Text] [Related]
14. Estrogen receptor alpha inhibits senescence-like phenotype and facilitates transformation induced by oncogenic ras in human mammary epithelial cells.
Liu Z; Wang L; Yang J; Bandyopadhyay A; Kaklamani V; Wang S; Sun LZ
Oncotarget; 2016 Jun; 7(26):39097-39107. PubMed ID: 27259243
[TBL] [Abstract][Full Text] [Related]
15. [Regulation of [12Asp]K-ras4B on transcriptional activity of estrogen receptor in endometrial carcinoma HEC-1A cell lines].
Gui LM; Wei LH; Xu MX; Wang JL; Zhong YC; Li XP; Tu Z; Sun PM; Ma DL
Zhonghua Fu Chan Ke Za Zhi; 2004 Jan; 39(1):30-4. PubMed ID: 14989985
[TBL] [Abstract][Full Text] [Related]
16. Opposing effects of Ras on p53: transcriptional activation of mdm2 and induction of p19ARF.
Ries S; Biederer C; Woods D; Shifman O; Shirasawa S; Sasazuki T; McMahon M; Oren M; McCormick F
Cell; 2000 Oct; 103(2):321-30. PubMed ID: 11057904
[TBL] [Abstract][Full Text] [Related]
17. ELF4/MEF activates MDM2 expression and blocks oncogene-induced p16 activation to promote transformation.
Sashida G; Liu Y; Elf S; Miyata Y; Ohyashiki K; Izumi M; Menendez S; Nimer SD
Mol Cell Biol; 2009 Jul; 29(13):3687-99. PubMed ID: 19380490
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of oncogene-mediated transformation by ectopic expression of p21Waf1 in NIH3T3 cells.
Michieli P; Li W; Lorenzi MV; Miki T; Zakut R; Givol D; Pierce JH
Oncogene; 1996 Feb; 12(4):775-84. PubMed ID: 8632899
[TBL] [Abstract][Full Text] [Related]
19. Mdm2 ligase dead mutants did not act in a dominant negative manner to re-activate p53, but promoted tumor cell growth.
Swaroop M; Sun Y
Anticancer Res; 2003; 23(4):3167-74. PubMed ID: 12926050
[TBL] [Abstract][Full Text] [Related]
20. RPL23 Links Oncogenic RAS Signaling to p53-Mediated Tumor Suppression.
Meng X; Tackmann NR; Liu S; Yang J; Dong J; Wu C; Cox AD; Zhang Y
Cancer Res; 2016 Sep; 76(17):5030-9. PubMed ID: 27402081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
